Keeping Current CME

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes

Nov 30, 2023

How confident are you in managing patients your patients on ROS1 inhibitor therapy?

Credit available for this activity expires: 11/30/24
Earn Credit / Learning Objectives & Disclosures:

What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs

Nov 28, 2023

Drs Nelson and Taylor discuss the key takeaways from all the presentations in the Women’s Health Master Class.

Credit available for this activity expires: 11/28/24
Earn Credit / Learning Objectives & Disclosures:

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

Nov 28, 2023

Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)?

Credit available for this activity expires: 11/21/24
Earn Credit / Learning Objectives & Disclosures:

Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

Nov 28, 2023

How do your treatment decisions compare with the experts?

Credit available for this activity expires: 11/28/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998763?ecd=bdc_podcast_libsyn_mscpedu

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

Nov 17, 2023

What strategies are you using to individualize treatment of HR+/HER2- early breast cancer?

Credit available for this activity expires: 11/17/24
Earn Credit / Learning Objectives & Disclosures: